Functionalization of iron oxide nanoparticles with biosurfactants and biocompatibility studies

Journal of Biomedical Nanotechnology

Volumn 9, Issue 5, 2013, Pages 751-764

  Sangeetha, J ^a   Thomas, Susha ^b   Arutchelvi, J ^b   Doble, Mukesh ^b   Philip, John ^a  

^a INDIRA GANDHI CENTRE FOR ATOMIC RESEARCH   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

Author keywords

Biocompatibility; Biosurfactants; Functionalization; Iron Oxide Nanoparticles; Surfactin

Indexed keywords

BIO-SURFACTANTS; EXTERNAL MAGNETIC FIELD; FUNCTIONALIZATIONS; FUNCTIONALIZED NANOPARTICLES; IRON OXIDE NANOPARTICLE; PHASE-CONTRAST MICROSCOPY; POLYETHYLENE GLYCOL (PEG); SURFACTIN;

BIOCOMPATIBILITY; BIOMOLECULES; CELL CULTURE; CYTOTOXICITY; DEXTRAN; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HYDRODYNAMICS; LIGHT POLARIZATION; LIPIDS; METAL NANOPARTICLES; THERMOGRAVIMETRIC ANALYSIS;

SURFACE ACTIVE AGENTS;

DEXTRAN; IRON OXIDE; MACROGOL; RHAMNOLIPID; SURFACTIN;

ADSORPTION; ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; HYDRODYNAMICS; INFRARED SPECTROSCOPY; MAGNETIC FIELD; MATERIAL COATING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARTICLE SIZE; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; FERRIC COMPOUNDS; FIBROBLASTS; HYDRODYNAMICS; MATERIALS TESTING; MICE; MODELS, BIOLOGICAL; NANOPARTICLES; PARTICLE SIZE; SURFACE-ACTIVE AGENTS; THERMOGRAVIMETRY;

EID: 84877763908     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1590     Document Type: Article

References (77)

1. M. M. Yallapu, S. F. Othman, E. T. Curtis, B. K. Gupta, M. Jaggi, and S. C. Chauhan, Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials 32, 1890 (2011).
2. R. R. Oliveira, F. S. Ferreira, E. R. Cintra, L. C. Branquinho, A. F. Bakuzis, and E. M. Lima, Magnetic nanoparticles and rapamycin encapsulated into polymeric nanocarriers. J. Biomed. Nanotech. 8, 193 (2012).
3. M. Namdeo, S. Saxena, R. Tankhiwale, M. Bajpai, Y. M. Mohan, and S. K. Bajpai, Magnetic nanoparticles for drug delivery applications. J. Nanosci. Nanotechnol. 8, 3247 (2008).
4. L. Yang, Z. Cao, H. K. Sajja, H. Mao, L. Wang, H. Geng, H. Xu, T. Jiang, W. C. Wood, S. Nie, and Y. A. Wang, Development of receptor targeted magnetic iron oxide nanoparticles for efficient drug delivery and tumor imaging. J. Biomed. Nanotech. 4, 439 (2008).
5. L. Zhang, F. Yu, A. J. Cole, B. Chertok, A. E. David, J. Wang, and V. C. Yang, Gum arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging. AAPS J. 2, 693 (2009).
6. M. Johannsen, U. Gneveckow, L. Eckelt, A. Feussner, N. Waldofner, R. Scholz, S. Deger, P. Wust, S. A. Loening, and A. Jordan, Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique. Int. J. Hyperthermia 21, 637 (2005).
7. C. Wilhelm, J. P. Fortin, and F. Gazeau, Tumour cell toxicity of intracellular hyperthermia mediated by magnetic nanoparticles. J. Nanosci. Nanotechnol. 7, 2933 (2007).
8. N. Kohler, C. Sun, A. Fichtenholtz, J. Gunn, C. Fang, and M. Zhang, Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small 2, 785 (2006).
9. C. Sun, J. S. H. Lee, and M. Zhang, Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug Deliv. Rev. 60, 1252 (2008).
10. T. Osaka, T. Matsunaga, T. Nakanishi, A. Arakaki, D. Niwa, and H. Iida, Synthesis of magnetic nanoparticles and their application to bioassays. Anal. Bioanal. Chem. 384, 593 (2006).
11. D. Sponarova, D. Horak, M. Trchova, P. Jendelova, V. Herynek, N. Mitina, A. Zaichenko, R. Stoika, P. Lesny, and E. Sykova, The use of oligoperoxide-coated magnetic nanoparticles to label stem cells. J. Biomed. Nanotech. 7, 384 (2011).
12. I. J. Bruce and T. Sen, Surface modification of magnetic nanoparticles with alkoxysilanes and their application in magnetic bioseparations. Langmuir 21, 7029 (2005).
13. C. Wilhelm and F. Gazeau, Universal cell labelling with anionic magnetic nanoparticles. Biomaterials 29, 3161 (2008).
14. M. A. Voinov, J. O. S. Pagan, E. Morrison, T. I. Smirnova, and A. I. Smirnov, Surface-mediated production of hydroxyl radicals as a mechanism of iron oxide nanoparticle biotoxicity. J. Am. Chem. Soc. 133, 35 (2011).
15. D. Hautot, Q. A. Pankhurst, N. Khan, and J. Dobson, Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue. Proc. R. Soc. Lond. B 270, S62 (2003).
16. X. Xue, K. Hanna, and N. Deng, Fenton-like oxidation of Rhodamine B in the presence of two types of iron (II, III) oxide. J. Hazard. Mater. 166, 407 (2009).
17. M. Geppert, M. Hohnholt, L. Gaetjen, I. Grunwald, M. Baumer, and R. Dringen, Accumulation of iron oxide nanoparticles by cultured brain astrocytes. J. Biomed. Nanotech. 5, 285 (2009).
18. M. Rahimi, A. Wadajkar, K. Subramanian, M. Yousef, W. Cui, J. T. Hsieh, and K. T. Nguyen, In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery. Nanomed. Nanotech. Biol. Med. 6, 672 (2010).
19. 4-chitosan nanoparticles used for hyperthermia. Adv. Powder Tech. 21, 461 (2010).
20. L. Zhu, J. Ma, N. Jia, Y. Zhao, and H. Shen, Chitosan-coated magnetic nanoparticles as carriers of 5-Fluorouracil: Preparation, characterization and cytotoxicity studies. Colloids Surf., B 68, 1 (2009).
21. 4 magnetic nanoparticles. Biochem. Eng. J. 42, 290 (2008).
22. Y. C. Chang, D. B. Shieh, C. H. Chang, and D. H. Chen, Conjugation of monodisperse chitosan-bound magnetic nanocarrier with epirubicin for targeted cancer therapy. J. Biomed. Nanotech. 1, 196 (2005).
23. H. L. Duan, Z. Q. Shen, X. W. Wang, F. H. Chao, and J. W. Li, Preparation of immunomagnetic iron-dextran nanoparticles and application in rapid isolation of E.coli O157:H7 from foods. World J. Gastroenterol. 11, 3660 (2005).
24. C. C. Berry, S. Wells, S. Charles, G. Aitchison, and A. S. G. Curtis, Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials 25, 5405 (2004).
25. S. A. Meenach, J. Z. Hilt, and K. W. Anderson, Poly(ethylene glycol)-based magnetic hydrogel nanocomposites for hyperthermia cancer therapy. Acta Biomater. 6, 1039 (2010).
26. A. J. Cole, A. E. David, J. Wang, C. J. Galban, H. L. Hill, and V. C. Yang, Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials 32, 2183 (2011).
27. 4/APTES/PEG diacid functionalized magnetic nanoparticles for MR imaging. Colloids Surf., A 328, 52 (2008).
28. C. Barrera, A. P. Herrera, and C. Rinaldi, Colloidal dispersions of monodisperse magnetite nanoparticles modified with poly(ethylene glycol). J. Colloid Interface Sci. 329, 107 (2009).
29. M. D. Butterworth, L. Illum, and S. S. Davis, Preparation of ultrafine silica- and PEG-coated magnetite particles. Colloids Surf., A 179, 93 (2001).
30. 4 nanoparticles as a protein delivery vehicle. Colloids Surf., A 350, 8 (2009).
31. W. S. Cho, M. Cho, J. Jeong, M. Choi, B. S. Han, H. S. Shin, J. Hong, B. H. Chung, J. Jeong, and M. H. Cho, Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol. 245, 116 (2010).
32. D. Vollenbroich, M. Ozel, J. Vater, R. M. Kamp, and G. Pauli, Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis. Biologicals 25, 289 (1997).
33. S. Y. Kim, J. Y. Kim, S. H. Kim, H. J. Bae, H. Yi, S. H. Yoon, B. S. Koo, M. Kwon, J. Y. Cho, C. E. Lee, and S. Hong, Surfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression. FEBS Lett. 581, 865 (2007).
34. G. Seydlova and J. Svobodova, Review of surfactin chemical properties and the potential biomedical applications. Cent. Eur. J. Med. 3, 123 (2008).
35. Z. Liao, H. Wang, X. Wang, C. Wang, X. Hu, X. Cao, and J. Chang, Biocompatible surfactin-stabilized superparamagnetic iron oxide nanoparticles as contrast agents for magnetic resonance imaging. Colloids Surf., A 370, 1 (2010).
36. O. Pornsunthorntawee, S. Chavadej, and R. Rujiravanit, Characterization and encapsulation efficiency of rhamnolipid vesicles with cholesterol addition. J. Biosci. Bioeng. 112, 102 (2011).
37. N. W. Gunther, A. Nunez, W. Fett, and D. K. Y. Solaiman, Production of rhamnolipids by Pseudomonas chlororaphis, a nonpathogenic bacterium. Appl. Environ. Microbiol. 71, 2288 (2005).
38. R. B. Lovaglio, F. J. d. Santos, M. J. Junior, and J. Contiero, Rhamnolipid emulsifying activity and emulsion stability: pH rules. Colloids Surf., B 85, 301 (2011).
39. S. G. V. A. O. Costa, M. Nitschke, F. Lepine, E. Deziel, and J. Contiero, Structure, properties and applications of rhamnolipids produced by Pseudomonas aeruginosa L2-1 from cassava wastewater. Process Biochem. 45, 1511 (2010).
40. L. M. Whang, P. W. G. Liu, C. C. Ma, and S. S. Cheng, Application of biosurfactants, rhamnolipid, and surfactin, for enhanced biodegradation of diesel-contaminated water and soil. J. Hazard. Mater. 151, 155 (2008).
41. M. A. M. E. Zeftawy and C. N. Mulligan, Use of rhamnolipid to remove heavy metals from wastewater by micellar-enhanced ultrafiltration (MEUF). Sep. Purif. Technol. 77, 120 (2011).
42. M. A. Hashim, S. Mukhopadhyay, J. N. Sahu, and B. Sengupta, Remediation technologies for heavy metal contaminated groundwater. J. Environ. Manage. 92, 2355 (2011).
43. M. Z. V. Gomes and M. Nitschke, Evaluation of rhamnolipid and surfactin to reduce the adhesion and remove biofilms of individual and mixed cultures of food pathogenic bacteria. Food Control 25, 441 (2012).
44. L. V. Araujo, F. Abreu, U. Lins, L. M. M. S. Anna, M. Nitschke, and D. M. G. Freire, Rhamnolipid and surfactin inhibit Listeria monocytogenes adhesion. Food Res. Int. 44, 481 (2011).
45. D. H. Dusane, Y. V. Nancharaiah, S. S. Zinjarde, and V. P. Venugopalan, Rhamnolipid mediated disruption of marine Bacillus pumilus biofilms. Colloids Surf., B 81, 242 (2010).
46. J. Arutchelvi, S. Bhaduri, P. V. Uppara, and M. Doble, Production and Characterization of Biosurfactant from Bacillus subtilis YB7. J. Appl. Sci. 9, 3151 (2009).
47. J. Arutchelvi and M. Doble, Characterization of glycolipid biosurfactant from Pseudomonas aeruginosa CPCL isolated from petroleumcontaminated soil. Lett. Appl. Microbiol. 51, 75 (2010).
48. G. Gnanaprakash, J. Philip, T. Jayakumar, and B. Raj, Effect of digestion time and alkali addition rate on physical properties of magnetite nanoparticles. J. Phys. Chem. B 111, 7978 (2007).
49. A. Bumb, M. W. Brechbiel, P. L. Choyke, L. Fugger, A. Eggeman, D. Prabhakaran, J. Hutchinson, and P. J. Dobson, Synthesis and characterization of ultra-small superparamagnetic iron oxide nanoparticles thinly coated with silica. Nanotech. 19, 335601 (2008).
50. T. T. L. Nguyen, A. Edelen, B. Neighbors, and D. A. Sabatini, Biocompatible lecithin-based microemulsions with rhamnolipid and sophorolipid biosurfactants: Formulation and potential applications. J. Colloid Interface Sci. 348, 498 (2010).
51. A. S. Porfire, I. Tomuta, J. M. Irache, and S. E. Leucuta, The influence of the formulation factors on physico-chemical properties of dextran associated Gantrez® AN nanoparticles. Farmacia 57, 463 (2009).
52. J. M. Harris, Poly(Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications, Plenum Press, New York (1992).
53. P. Wu, J. Zhu, and Z. Xu, Template-Assisted Synthesis of Mesoporous Magnetic Nanocomposite Particles. Adv. Funct. Mater. 14, 345 (2004).
54. R. J. H. Stenekes, H. Talsma, and W. E. Hennink, Formation of dextran hydrogels by crystallization. Biomaterials 22, 1891 (2001).
55. M. Tang, H. Dou, and K. Sun, One-step synthesis of dextranbased stable nanoparticles assisted by self-assembly. Polymer 47, 728 (2006).
56. J. Amici, M. U. Kahveci, P. Allia, P. Tiberto, Y. Yagci, and M. Sangermano, Polymer grafting onto magnetite nanoparticles by "click" reaction. J. Mater. Sci. 47, 412 (2012).
57. C. Peniche, W. A. Monal, N. Davidenko, R. Sastre, A. Gallardo, and J. S. Roman, Self-curing membranes of chitosan/PAA IPNs obtained by radical polymerization: Preparation, characterization and interpolymer complexation. Biomaterials 20, 1869 (1999).
58. A. F. Faria, D. S. T. Martinez, G. N. O. Barbosa, B. G. Vaz, I. S. Silva, J. S. Garcia, M. R. Totola, M. N. Eberlin, M. Grossman, O. L. Alves, and L. R. Durrant, Production and structural characterization of surfactin (C14/Leu7- produced by Bacillus subtilis isolate LSFM-05 grown on raw glycerol from the biodiesel industry. Process Biochem. 46, 1951 (2011).
59. Y. P. Guo, Y. Y. Hu, R. R. Gu, and H. Lin, Characterization and micellization of rhamnolipidic fractions and crude extracts produced by Pseudomonas aeruginosa mutant MIG-N146. J. Colloid Interface Sci. 331, 356 (2009).
60. 4/polyethylene glycol composite nanoparticles with core-shell structure. J. Alloys Compd. 502, 392 (2010).
61. 4 nanoparticles. J. Biomed. Mater. Res. A 80, 333 (2007).
62. Y. Shen, X. Wang, A. Xie, L. Huang, J. Zhu, and L. Chen, Synthesis of dextran/Se nanocomposites for nanomedicine application. Mater. Chem. Phys. 109, 534 (2008).
63. J. Philip, P. D. Shima, and B. Raj, Enhancement of thermal conductivity in magnetite based nanofluid due to chainlike structures. Appl. Phys. Lett. 91, 203108 (2007).
64. M. T. A. Eloi, J. L. Santos, P. C. Morais, and A. F. Bakuzis, Fieldinduced columnar transition of biocompatible magnetic colloids: An aging study by magnetotransmissivity. Phys. Rev. E 82, 021407 (2010).
65. V. Socoliuc, D. Bica, and L. Vekas, Magnetically induced phase condensation with asymptotic critical temperature in an aqueous magnetic colloid. Magnetohydrodynamics 47, 201 (2011).
66. K. S. Neto, A. F. Bakuzis, G. R. R. Goncalves, F. Pelegrini, and P. C. Morais, Evidence of phase separation in magnetic colloids using magnetic resonance. J. Magn. Magn. Mater. 289, 129 (2005).
67. J. C. Bacri, R. Perzynski, D. Salin, V. Cabuil, and R. Massart, Phase diagram of an ionic magnetic colloid: Experimental study of the effect of ionic strength. J. Colloid Interface Sci. 132, 43 (1989).
68. A. O. Ivanov, Phase separation in magnetic colloids. J. Magn. Magn. Mater. 201, 234 (1999).
69. C. Holm and J. J. Weis, The structure of ferrofluids: A status report. Curr. Opin. Colloid Interface Sci. 10, 133 (2005).
70. Y. Rao, Nanofluids: Stability, phase diagram, rheology and applications. Particuology 8, 549 (2010).
71. F. M. Pedrero, M. T. Miranda, A. Schmitt, F. Vereda, and J. C. Fernandez, Structure and stability of aggregates formed by electrical double-layered magnetic particles. Colloids Surf., A 306, 158 (2007).
72. P. K. Prabhakar, S. Vijayaraghavan, J. Philip, and M. Doble, Biocompatibility Studies of Functionalized CoFe2O4 Magnetic Nanoparticles. Current Nanoscience 7, 371 (2011).
73. M. Mahmoudi, A. Simchi, and M. Imani, Cytotoxicity of uncoated and polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles. J. Phys. Chem. C 113, 9573 (2009).
74. J. Sabo, L. Mirossay, L. Horovcak, M. Sarissky, A. Mirossay, and J. Mojzis, Effects of static magnetic field on human leukemic cell line HL-60. Bioelectrochemistry 56, 227 (2002).
75. J. E. Bae, M.I. Huh, B. K. Ryu, J. Y. Do, S. U. Jin, M. J. Moon, J. C. Jung, Y. Chang, E. Kim, S. G. Chi, G. H. Lee, and K. S. Chae, The effect of static magnetic fields on the aggregation and cytotoxicity of magnetic nanoparticles. Biomaterials 32, 9401 (2011).
76. M. H. A. Guedes, N. Sadeghiani, D. Lima, G. Peixoto, J. P. Coelho, L. S. Barbosa, R. B. Azevedo, S. Kuckelhaus, M. F. D. Silva, P. C. Morais, and Z. G. M. Lacava, Effects of AC magnetic field and carboxymethyldextran-coated magnetite nanoparticles on mice peritoneal cells. J. Magn. Magn. Mater. 293, 283 (2005).
77. M. H. A. Guedes, M. E. A. Guedes, P. C. Morais, M. F. D. Silva, T. S. Santos, J. P. Alves, C. E. Bertelli, R. B. Azevedo, and Z. G. M. Lacava, Proposal of a magnetohyperthermic system: Preliminary biological tests. J. Magn. Magn. Mater. 272-276, 2406 (2004).